India is preparing to launch a comprehensive audit of drug approvals spanning 81 years, aiming to update records for drugs approved by the Drugs Controller General of India that are missing from its database. The initiative covers legacy licences dating back to 1945, when India’s drug laws were first enacted, according to livemint.com.
The government’s plan involves a massive trace-and-track exercise to identify discrepancies in the Central Drugs Standard Control Organisation’s database. This effort seeks to create a comprehensive repository of missing drug approvals, ensuring that all drugs approved over the decades are properly documented. The initiative is part of a broader effort to address safety concerns related to drug approvals.
This audit is significant as it addresses longstanding gaps in the regulatory records that could impact drug safety and compliance. By resolving discrepancies and updating the database, the government aims to strengthen oversight and transparency in the pharmaceutical sector. The move follows growing concerns about the accuracy and completeness of drug approval data maintained by regulatory authorities.
The audit will cover approvals issued since 1945, marking a historic review of India’s drug regulatory framework. The government has not specified a timeline for completion, but the exercise represents one of the most extensive efforts to reconcile decades of drug approval records, as reported by livemint.com.